DAVID MICHAEL ARMSTRONG

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health NORTH TONAWANDA, NY NPI 1962048793

General Payments — all program years on this page

$3,928.38

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,666.50 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,666.5019

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $483.7010
2022 $296.555
2023 $1,481.6326
2024 $1,666.5019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100484975 Novo Nordisk Inc $124.99 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100537111 Novo Nordisk Inc $13.26 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100567240 Novo Nordisk Inc $9.03 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100589727 Novo Nordisk Inc $12.25 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104472856 AstraZeneca Pharmaceuticals LP $125.83 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104597868 AstraZeneca Pharmaceuticals LP $111.38 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105449318 AstraZeneca Pharmaceuticals LP $15.61 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105620561 AstraZeneca Pharmaceuticals LP $124.99 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105752065 AstraZeneca Pharmaceuticals LP $124.99 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113924916 Paratek Pharmaceuticals, Inc. $124.99 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115428886 Amgen Inc. $124.99 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116468320 GlaxoSmithKline, LLC. $20.53 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116729684 GlaxoSmithKline, LLC. $124.99 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117496648 Amgen Inc. $101.72 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119017618 Otsuka America Pharmaceutical, Inc. $18.27 04/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129461702 Esperion Therapeutics, Inc. $124.99 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135603507 Lilly USA, LLC $124.99 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151145736 Phathom Pharmaceuticals, Inc. $113.71 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151145738 Phathom Pharmaceuticals, Inc. $124.99 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.